Fosun Pharma For Profit

上海复星医药集团(“复星医药”,股票代码:600196.SH,02196.HK)成立于1994 年,是一家植根中国、创新驱动的全球化医药健康产业集团,直接运营的业务包括制药、医疗器械与医学诊断、医疗健康服务,并通过参股国药控股覆盖到医药商业领域。

Last Funding Type: Debt Financing
Funding Status: M&A
Headquarters: Shanghai, Shanghai, China
Founded Date: 1994-01-01
Investor Type: Venture Capital
Last Funding Date: 2023-06-06
Total Funding: 53487377
Employee Number: 10001+
Number Of Exists: 11
Estimated Revenue: RMB 43.952 billion
Investors Number: 1
Industry: Longevity Biomarkers